Endocan and Erectile Dysfunction.
Inflammation
endothelial dysfunction
sexuality
Journal
American journal of men's health
ISSN: 1557-9891
Titre abrégé: Am J Mens Health
Pays: United States
ID NLM: 101287723
Informations de publication
Date de publication:
Historique:
entrez:
13
12
2019
pubmed:
13
12
2019
medline:
23
10
2020
Statut:
ppublish
Résumé
Endothelial dysfunction (ED) occurs early in the development of atherosclerosis. Predictors of vascular risk including obesity, hyperlipidemia, metabolic syndrome, diabetes mellitus, and hypertension are associated with both vascular endothelial and ED. Endocan is a novel marker of endothelial dysfunction, inflammation, and atherosclerosis. Raised endocan levels (usually measured by ELISA assays) were reported in some cardiovascular diseases and related conditions. Increased endocan levels may represent the endothelial and inflammatory components of the pathogenesis of ED and may, therefore, prove useful in clinical practice.
Identifiants
pubmed: 31829075
doi: 10.1177/1557988319893889
pmc: PMC6909267
doi:
Substances chimiques
Biomarkers
0
ESM1 protein, human
0
Neoplasm Proteins
0
Proteoglycans
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1557988319893889Références
Atherosclerosis. 2015 Nov;243(1):339-43
pubmed: 26448266
Sci Rep. 2019 Apr 11;9(1):5929
pubmed: 30976039
Curr Opin Cardiol. 2015 Jul;30(4):416-21
pubmed: 26049392
Curr Urol. 2016 Oct;9(3):119-123
pubmed: 27867328
Kidney Int. 2014 Dec;86(6):1213-20
pubmed: 24988065
Medicine (Baltimore). 2018 Dec;97(49):e13407
pubmed: 30544417
Andrologia. 2018 Dec;50(10):e13113
pubmed: 30039584
Int Urol Nephrol. 2018 Sep;50(9):1577-1582
pubmed: 30054863
Br J Dermatol. 2013 Nov;169(5):1066-70
pubmed: 23889284
Angiology. 2016 Sep;67(8):749-55
pubmed: 26614790
Int J Impot Res. 2014 Jul-Aug;26(4):124-7
pubmed: 24352245
Int J Impot Res. 2017 Jul;29(4):175-178
pubmed: 28424502
Blood Press. 2015 Feb;24(1):55-60
pubmed: 25390761
J Am Acad Dermatol. 2014 Feb;70(2):291-6
pubmed: 24176522